For its first fiscal quarter (ending March 31), Bausch Health Cos Inc (NYSE: BHC) has reported E.P.S. of $-0.17 compared to $-0.55 a year ago. This performance was $-1.00 short of the consensus estimate of $0.82. E.P.S. were $-1.24 for the latest four quarters through March 31 versus $-0.98 for the same period a year ago.
Recent Price Action
On 5/2/24, Bausch Health Cos Inc (NYSE: BHC) stock suffered a large decline of -7.5%, closing at $8.09. Moreover, trading volume in this decline was exceptionally high at 204% of normal. Relative to the market the stock has been strong over the last nine months but has declined -5.5% during the last week.
Current PriceTarget Research Rating
BHC is expected to be an important Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment